Abstract
The mechanisms by which stressful life events increase the risk of relapse in recovering cocaine addicts are not well understood. We previously reported that stress, via elevated corticosterone, potentiates cocaine-primed reinstatement of cocaine seeking following self-administration in rats and that this potentiation appears to involve corticosterone-induced blockade of dopamine clearance via the organic cation transporter 3 (OCT3). In the present study, we use a conditioned place preference/reinstatement paradigm in mice to directly test the hypothesis that corticosterone potentiates cocaine-primed reinstatement by blockade of OCT3. Consistent with our findings following self-administration in rats, pretreatment of male C57/BL6 mice with corticosterone (using a dose that reproduced stress-level plasma concentrations) potentiated cocaine-primed reinstatement of extinguished cocaine-induced conditioned place preference. Corticosterone failed to re-establish extinguished preference alone but produced a leftward shift in the dose–response curve for cocaine-primed reinstatement. A similar potentiating effect was observed upon pretreatment of mice with the non-glucocorticoid OCT3 blocker, normetanephrine. To determine the role of OCT3 blockade in these effects, we examined the abilities of corticosterone and normetanephrine to potentiate cocaine-primed reinstatement in OCT3-deficient and wild-type mice. Conditioned place preference, extinction and reinstatement of extinguished preference in response to low-dose cocaine administration did not differ between genotypes. However, corticosterone and normetanephrine failed to potentiate cocaine-primed reinstatement in OCT3-deficient mice. Together, these data provide the first direct evidence that the interaction of corticosterone with OCT3 mediates corticosterone effects on drug-seeking behavior and establish OCT3 function as an important determinant of susceptibility to cocaine use.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Aliczki M, Zelena D, Mikics E, Varga ZK, Pinter O, Bakos NV et al (2013). Monoacylglycerol lipase inhibition-induced changes in plasma corticosterone levels, anxiety and locomotor activity in male CD1 mice. Horm Behav 63: 752–758.
Amphoux A, Vialou V, Drescher E, Bruss M, La Cour CM, Rochat C et al (2006). Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology 50: 941–952.
Baganz NL, Horton RE, Calderon AS, Owens WA, Munn JL, Watts LT et al (2008). Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc Natl Acad Sci USA 105: 18976–18981.
Baganz N, Horton R, Martin K, Holmes A, Daws LC (2010). Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gun. J Neurosci 30: 15185–15195.
Baker DA, Tran-Nguyen TL, Fuchs RA, Neisewander JL (2001). Influence of individual differences and chronic fluoxetine treatment on cocaine-seeking behavior in rats. Psychopharmacology 155: 18–26.
Burmeister JJ, Lungren EM, Kirschner KF, Neisewander JL (2004). Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats. Neuropsychopharmacology 29: 660–668.
Cui M, Aras R, Christian WV, Rappold PM, Hatwar M, Panza J, Jackson-Lewis V et al (2009). The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proc Natl Acad Sci USA 106: 8043–8048.
Daws LC (2009). Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy. Pharmacol Ther 121: 89–99.
Duan H, Wang J (2010). Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3. J Pharmacol Exp Ther 335: 743–753.
Engel K, Zhou M, Wang J (2004). Identification and characterization of a novel monoamine transporter in the human brain. J Biol Chem 279: 50042–50049.
Erb S, Hitchcott PK, Rajabi H, Mueller D, Shaham Y, Stewart J (2000). Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology 23: 138–150.
Fletcher PJ, Grottick AJ, Higgins GA (2002). Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology 27: 576–586.
Gasser PJ, Lowry CA, Orchinik M (2006). Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission. J Neurosci 26: 8758–8766.
Gasser PJ, Orchinik M, Raju I, Lowry CA (2009). Distribution of organic cation transporter 3, a corticosterone-sensitive monoamine transporter, in the rat brain. J Comp Neurol 512: 529–555.
Gong S, Miao YL, Jiao GZ, Sun MJ, Li H, Lin J et al (2015). Dynamics and correlation of serum cortisol and corticosterone under different physiological or stressful conditions in mice. PLoS One 10: e0117503.
Gorboulev V, Shatskaya N, Volk C, Koepsell H (2005). Subtype-specific affinity for corticosterone of rat organic cation transporters rOCT1 and rOCT2 depends on three amino acids within the substrate binding region. Mol Pharmacol 67: 1612–1619.
Graf EN, Wheeler RA, Baker DA, Ebben AL, Hill JE, McReynolds JR et al (2013). Corticosterone acts in the nucleus accumbens to enhance dopamine signaling and potentiate reinstatement of cocaine seeking. J Neurosci 33: 11800–11810.
Gründemann D, Köster S, Kiefer N, Breidert T, Engelhardt M, Spitzenberger F et al (1998a). Transport of monoamine transmitters by the organic cation transporter type 2, OCT2. J Biol Chem 273: 30915–30920.
Gründemann D, Schechinger B, Rappold GA, Schömig E (1998b). Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1: 349–351.
Gründemann D, Liebich G, Kiefer N, Köster S, Schömig E (1999). Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol 56: 1–10.
Horvath G, Sutto Z, Torbati A, Conner GE, Salathe M, Wanner A (2003). Norepinephrine transport by the extraneuronal monoamine transporter in human bronchial arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 285: L829–L837.
Iversen LL, Salt PJ (1970). Inhibition of catecholamine uptake-2 by steroids in the isolated rat heart. Br J Pharmacol 40: 528–530.
Langer SZ, Rubio MC (1973). Effects of the noradrenaline metabolites on the adrenergic receptors. Naunyn Schmiedebergs Arch Pharmacol 276: 71–88.
Lenz T, Werle E, Strobel G, Weicker H (1991). O-Methylated and sulfoconjugated catecholamines: differential activities at human platelet alpha 2-adrenoceptors. Can J Physiol Pharmacol 69: 929–937.
Mantsch JR, Weyer A, Vranjkovic O, Beyer CE, Baker DA, Caretta H (2010). Involvement of noradrenergic neurotransmission in the stress- but not cocaine-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: role for β-2 adrenergic receptors. Neuropsychopharmacology 35: 2165–2178.
Malisch JL, Saltzman W, Gomes FR, Rezende EL, Jeske DR, Garland T Jr. (2007). Baseline and stress-induced plasma corticosterone concentrations of mice selectively bred for high voluntary wheel running. Physiol Biochem Zool 80: 146–156.
Martel F, Ribeiro L, Calhau C, Azevedo I (1999). Comparison between uptake2 and rOCT1: effects of catecholamines, metanephrines and corticosterone. Naunyn Schmiedebergs Arch Pharmacol 359: 303–309.
McReynolds JR, Doncheck EM, Vranjkovic O, Ganzman GS, Baker DA, Hillard CJ, Mantsch JR (2016). CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats. Psychopharmacology 233: 99–109.
Nic Dhonnchadha BA, Fox RG, Stutz SJ, Rice KC, Cunningham KA (2009). Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model. Behav Neurosci 123: 382–396.
Platt DM, Rowlett JK, Spealman RD (2007). Noradrenergic mechanisms in cocaine-induced reinstatement of drug seeking in squirrel monkeys. J Pharmacol Exp Ther 322: 894–902.
Schomig E, Russ H, Staudt K, Martel F, Gliese M, Grundemann D (1998). The extraneuronal monoamine transporter exists in human central nervous system glia. Adv Pharmacol 42: 356–359.
Schmitt A, Mössner R, Gossmann A, Fischer IG, Gorboulev V, Murphy DL et al (2003). Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice. J Neurosci Res 71: 701–709.
Shang T, Uihlein AV, Van Asten J, Kalyanaraman B, Hillard CJ (2003). 1-Methyl-4-phenylpyridinium accumulates in cerebellar granule neurons via organic cation transporter 3. J Neurochem 85: 358–367.
Shen HW, Hagino Y, Kobayashi H, Shinohara-Tanaka K, Ikeda K, Yamamoto H et al (2004). Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology 29: 1790–1799.
Sinha R, Catapano D, O'Malley S (1999). Stress-induced craving and stress response in cocaine dependent individuals. Psychopharmacology 142: 343–351.
Sinha R, Garcia M, Paliwal P, Kreek MJ, Rounsaville BJ (2006). Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry 63: 324–331.
Vialou V, Amphoux A, Zwart R, Giros B, Gautron S (2004). Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation. J Neurosci 24: 2846–2851.
Vialou V, Balasse L, Callebert J, Launay JM, Giros B, Gautron S (2008). Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice. J Neurochem 106: 1471–1482.
Vranjkovic O, Hang S, Baker DA, Mantsch JR (2012). Beta adrenergic receptor mediation of stress-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: roles for beta-1 and beta-2 adrenergic receptors. J Pharmacol Exp Ther 342: 541–551.
Zhang XY, Kosten TA (2005). Prazosin, an alpha-1 adrenergic antagonist, reduces cocaine-induced reinstatement of drug seeking. Biol Psychiatry 57: 1202–1204.
Zwart R, Verhaagh S, Buitelaar M, Popp-Snijders C, Barlow DP (2001). Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice. Mol Cell Biol 21: 4188–4196.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Rights and permissions
About this article
Cite this article
McReynolds, J., Taylor, A., Vranjkovic, O. et al. Corticosterone Potentiation of Cocaine-Induced Reinstatement of Conditioned Place Preference in Mice is Mediated by Blockade of the Organic Cation Transporter 3. Neuropsychopharmacol 42, 757–765 (2017). https://doi.org/10.1038/npp.2016.187
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2016.187
This article is cited by
-
Ethanol inhibits dopamine uptake via organic cation transporter 3: Implications for ethanol and cocaine co-abuse
Molecular Psychiatry (2023)
-
Chronically dysregulated corticosterone impairs dopaminergic transmission in the dorsomedial striatum by sex-divergent mechanisms
Neuropsychopharmacology (2023)
-
Neuroinflammatory Response in Reward-Associated Psychostimulants and Opioids: A Review
Cellular and Molecular Neurobiology (2023)
-
Increased cocaine reward in offspring of females exposed to morphine during adolescence
Psychopharmacology (2019)
